Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Kim, Haesook
Item TypeName
Academic Article Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age.
Academic Article Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.
Academic Article Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens.
Academic Article Rituximab for steroid-refractory chronic graft-versus-host disease.
Academic Article Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome.
Academic Article Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation.
Academic Article Improved survival in lymphoma patients receiving sirolimus for graft-versus-host disease prophylaxis after allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning.
Academic Article Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation.
Academic Article Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission.
Academic Article Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and mini-methotrexate (Tac/Sir/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
Academic Article Hyperlipidemia and statin use after allogeneic hematopoietic stem cell transplantation.
Academic Article Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation.
Academic Article Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease.
Academic Article Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopes.
Academic Article Reduced-intensity conditioning stem cell transplantation: comparison of double umbilical cord blood and unrelated donor grafts.
Academic Article Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.
Academic Article Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia.
Academic Article High levels of B-cell activating factor in patients with active chronic graft-versus-host disease.
Academic Article Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantation.
Academic Article Does iron overload really matter in stem cell transplantation?
Academic Article Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation.
Academic Article Sirolimus, tacrolimus, and low-dose methotrexate as graft-versus-host disease prophylaxis in related and unrelated donor reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
Academic Article Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.
Academic Article Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation.
Academic Article Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors.
Academic Article Reduced-intensity conditioning hematopoietic stem cell transplantation in patients over 60 years: hematologic malignancy outcomes are not impaired in advanced age.
Academic Article Low telomerase activity in CD4+ regulatory T cells in patients with severe chronic GVHD after hematopoietic stem cell transplantation.
Academic Article Interleukin-2 and regulatory T cells in graft-versus-host disease.
Academic Article Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease.
Academic Article Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation.
Academic Article Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation.
Concept Graft vs Host Disease
Academic Article Phase I study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host disease.
Academic Article Clinical endpoints in allogeneic hematopoietic stem cell transplantation studies: the cost of freedom.
Academic Article Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial.
Academic Article Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease.
Academic Article Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation.
Academic Article A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease.
Academic Article Sequential infusion of donor-derived dendritic cells with donor lymphocyte infusion for relapsed hematologic cancers after allogeneic hematopoietic stem cell transplantation.
Academic Article Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcome.
Academic Article Efficacy of immune suppression tapering in treating relapse after reduced intensity allogeneic stem cell transplantation.
Academic Article A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial.
Academic Article Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD.
Academic Article The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial.
Academic Article Circulating T follicular helper cells with increased function during chronic graft-versus-host disease.
Academic Article Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease.
Grant Mechanisms, Prevention and Treatment of Chronic Graft-vs.-Host Disease
Grant Immune Modulation/Hematopoietic Cell Transplantation
Academic Article Donor and recipient sex in allogeneic stem cell transplantation: what really matters.
Academic Article A phase I study of CD25/regulatory T-cell-depleted donor lymphocyte infusion for relapse after allogeneic stem cell transplantation.
Academic Article Low-dose IL-2 selectively activates subsets of CD4+ Tregs and NK cells.
Academic Article PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy.
Academic Article Venous thromboembolism is associated with graft-versus-host disease and increased non-relapse mortality after allogeneic hematopoietic stem cell transplantation.
Academic Article Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.
Academic Article Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host disease.
Academic Article Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II results.
Academic Article Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease.
Academic Article A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort Analysis.
Academic Article Effect of Antihuman T Lymphocyte Globulin on Immune Recovery after Myeloablative Allogeneic Stem Cell Transplantation with Matched Unrelated Donors: Analysis of Immune Reconstitution in a Double-Blind Randomized Controlled Trial.
Academic Article Efficacy and immunologic effects of extracorporeal photopheresis plus interleukin-2 in chronic graft-versus-host disease.
Academic Article Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease.
Academic Article Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem Cell Transplantation: An Ancillary Analysis of a Randomized Controlled Trial Comparing Tacrolimus/Sirolimus and Tacrolimus/Methotrexate (Blood and Marrow Transplant Clinical Trials Network/BMT CTN 0402).
Academic Article Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and children.
Academic Article Assessment of a multi-cytokine profile by a novel biochip-based assay allows correlation of cytokine profiles with clinical outcomes in adult recipients of umbilical cord blood transplantation.
Academic Article Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation.
Academic Article A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation.
Academic Article Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host disease.
Academic Article Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents.
Academic Article Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease.
Academic Article Correction: Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease.
Academic Article Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide.
Academic Article COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience.
Academic Article Ibrutinib in Steroid-Refractory Chronic Graft-versus-Host Disease, a Single-Center Experience.
Search Criteria
  • Graft vs Host Disease
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.